Paper6381007
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
Scheen A and 6 others. Diabetes Care, 1984. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Papers, record 6381007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6381007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Glucose | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Insulin Infusion Systems | Major topic |
| 3-Hydroxybutyric Acid | |
| Adult | |
| Alanine | |
| C-Peptide | |
| Drug Administration Schedule | |
| Fatty Acids, Nonesterified | |
| Female | |
| Glucagon | |
| Glycerol | |
| Humans | |
| Hydroxybutyrates | |
| Insulin | |
| Male | |
| Middle Aged |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21722597 | Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system). | J Diabetes Sci Technol | 2011 | https://conductscience.org/library/papers/21722597 | PubMed |
| 20200307 | Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20200307 | PubMed |
| 6357909 | Insulin treatment: a non-stop revolution. | Diabetologia | 1983 | https://conductscience.org/library/papers/6357909 | PubMed |
| 3899451 | Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/3899451 | PubMed |
| 2687064 | Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. | Diabetologia | 1989 | https://conductscience.org/library/papers/2687064 | PubMed |
| 2509271 | Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. | Diabetologia | 1989 | https://conductscience.org/library/papers/2509271 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6381007
GET https://conductscience.org/api/papers/v1/6381007/authors